Interim – Page 2 – Communicable Diseases Research

Real-world serological responses to extended-interval and heterologous COVID-19 mRNA vaccination in frail, older people (UNCoVER): an interim report from a prospective observational cohort study

Observational Study

Published on 2022-03-012022-10-05
Journal: The Lancet. Healthy longevity [Category] COVID19(2023년), SARS, 임상, 진단,

Interim analysis of a multicenter registry study of COVID-19 patients with inflammatory bowel disease in Japan (J-COSMOS)

Observational Study

Published on 2022-01-282022-10-04
Journal: Journal of Gastroenterology [Category] MERS, SARS, 임상,

[키워드] age Analysis analyzed Anti-TNF-α antibodies antibodies BMI body mass index Clinical course Cohort conditions coronavirus disease COVID-19 COVID-19 patient COVID-19 severity COVID-19 symptom COVID19 diagnosed with COVID-19 Disease activity had no Health IBD incidence independent risk factor Inflammatory bowel disease Interim Japan Japanese Logistic regression analysis majority multicenter Necrosis nine Older age Patient patients patients with COVID-19 receiving Registered Result SARS-CoV-2 Severe case severity Sex Spread steroid supplementary material the WHO Treatment vaccination with COVID-19
[DOI] 10.1007/s00535-022-01851-1 PMC 바로가기 [Article Type] Observational Study

Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine: Updated Interim Recommendations from the Advisory Committee on Immunization Practices — United States, December 2021

Full Report

Published on 2022-01-212022-10-30
Journal: Morbidity and Mortality Weekly Report [Category] COVID-19,

[키워드] Committee COVID-19 Interim janssen Johnson & Johnson Practice United States
[DOI] 10.15585/mmwr.mm7103a4 PMC 바로가기 [Article Type] Full Report

Interim Estimate of Vaccine Effectiveness of BNT162b2 (Pfizer-BioNTech) Vaccine in Preventing SARS-CoV-2 Infection Among Adolescents Aged 12–17 Years — Arizona, July–December 2021

12~17세 사이의 SARS-CoV-2 감염 예방에 대한 BNT162b2(화이자-바이오엔텍) 백신의 백신 효과 중간 추정 — 아리조나, 2021년 7~12월

Full Report

Published on 2021-12-312022-09-10
Journal: Morbidity and Mortality Weekly Report [Category] 변종,

[키워드] Adolescent estimate Interim of BNT162b2 Pfizer-BioNTech Preventing SARS-CoV-2 Year
[DOI] 10.15585/mmwr.mm705152a2 PMC 바로가기 [Article Type] Full Report

Reduced Humoral Response of SARS-CoV-2 Antibodies following Vaccination in Patients with Inflammatory Rheumatic Diseases—An Interim Report from a Danish Prospective Cohort Study

Communication

Published on 2021-12-282022-10-28
Journal: Vaccines [Category] COVID-19,

[키워드] 95% confidence interval Administered age Antibody Response Antibody test baseline biologic Bloods BNT162b2 vaccine Booster vaccine Cambridge Clinical data collected Combination combination therapy COVID-19 pandemic COVID-19 vaccine cut-off defined detection determine disease Disease activity drug Efficacy Gender Germany Healthcare provider Humoral response IgG IgG level IgG response immune response Immunoglobulin information Interim Mainz median medians Moderna mRNA-1273 vaccine Musculoskeletal National Outpatient Patient patient reported outcome patients treated Pfizer Prospective prospective cohort study psoriatic arthritis receiving report reported response Result rheumatoid arthritis risk RMD SARS-CoV-2 SARS-CoV-2 antibody SARS-CoV-2 IgG SARS-CoV-2 vaccination SARS-CoV-2 vaccine significant increase significantly higher significantly lower study population tested the median the SARS-CoV-2 Thermofisher treated Treatment USA vaccination Vaccine was measured was used were used
[DOI] 10.3390/vaccines10010035 PMC 바로가기 [Article Type] Communication

The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5–11 Years — United States, November 2021

Full Report

Published on 2021-11-122022-10-30
Journal: Morbidity and Mortality Weekly Report [Category] COVID-19, MERS,

[키워드] Committee COVID-19 Interim Pfizer-BioNTech United States Year
[DOI] 10.15585/mmwr.mm7045e1 PMC 바로가기 [Article Type] Full Report

Longitudinal Neurocognitive and Pulmonological Profile of Long COVID-19: Protocol for the COVIMMUNE-Clin Study

Protocol

Published on 2021-11-112022-10-29
Journal: JMIR Research Protocols [Category] COVID-19,

[키워드] adjusted age and sex Asymptomatic baseline Biomarker Brain characterized clinical clinical assessments Cognition Cohort cohort study comparison Complete complex Concentration contribute control group Course COVID-19 Data analysis defined diffusion capacity disease severity distribution Effect enrolled evaluated executive expected extreme Factors fatigue Final Follow-up Frequency healthy control healthy controls Identifier include information Interim knowledge Long longitudinal longitudinal analysis lung Lung function magnetic resonance imaging memory Mild neurocognitive neurodegeneration neurological Neuropsychology no symptom objective olfactory pandemic participant Patient patient cohort patient group performed physical pilot study positive postacute COVID-19 syndrome problems profile Psychiatric quantified Questionnaires recall recruited recruitment Registration registry report Result robust SARS-CoV-2 SARS-COV-2 infection screenings Severe case severe disease course stratified submission taste dysfunction tested the healthy these symptom verbal Volume volumetric World Health Organization
[DOI] 10.2196/30259 PMC 바로가기 [Article Type] Protocol

The Advisory Committee on Immunization Practices’ Interim Recommendations for Additional Primary and Booster Doses of COVID-19 Vaccines — United States, 2021

Full Report

Published on 2021-11-052022-10-30
Journal: Morbidity and Mortality Weekly Report [Category] COVID-19, MERS,

[키워드] Committee COVID-19 Interim United States
[DOI] 10.15585/mmwr.mm7044e2 PMC 바로가기 [Article Type] Full Report

Interim Estimates of COVID-19 Vaccine Effectiveness Against COVID-19–Associated Emergency Department or Urgent Care Clinic Encounters and Hospitalizations Among Adults During SARS-CoV-2 B.1.617.2 (Delta) Variant Predominance — Nine States, June–August 2021

SARS-CoV-2 B.1.617.2(델타) 변종 우세 — 9개 주, 2021년 6월–8월 중 성인의 COVID-19 관련 응급실 또는 긴급 치료 클리닉 조우 및 입원에 대한 COVID-19 백신 효과의 중간 추정

Full Report

Published on 2021-09-172022-09-10
Journal: Morbidity and Mortality Weekly Report [Category] SARS, 변종,

[키워드] Against B.1.617.2 clinic COVID-19 Delta Department Emergency encounter estimate Interim SARS-CoV-2
[DOI] 10.15585/mmwr.mm7037e2 PMC 바로가기 [Article Type] Full Report

Prospective Cohort Study of the Kinetics of Specific Antibodies to SARS-CoV-2 Infection and to Four SARS-CoV-2 Vaccines Available in Serbia, and Vaccine Effectiveness: A 3-Month Interim Report

Article

Published on 2021-09-172022-10-28
Journal: Vaccines [Category] COVID-19,